Literature DB >> 28297651

Glycan Determinants of Heparin-Tau Interaction.

Jing Zhao1, Isabelle Huvent2, Guy Lippens3, David Eliezer4, Anqiang Zhang5, Quanhong Li6, Peter Tessier7, Robert J Linhardt8, Fuming Zhang9, Chunyu Wang10.   

Abstract

Tau aggregates into paired helical filaments within neurons, a pathological hallmark of Alzheimer's disease. Heparin promotes tau aggregation and recently has been shown to be involved in the cellular uptake of tau aggregates. Although the tau-heparin interaction has been extensively studied, little is known about the glycan determinants of this interaction. Here, we used surface plasmon resonance (SPR) and NMR spectroscopy to characterize the interaction between two tau fragments, K18 and K19, and several polysaccharides, including heparin, heparin oligosaccharides, chemically modified heparin, and related glycans. Using a heparin-immobilized chip, SPR revealed that tau K18 and K19 bind heparin with a KD of 0.2 and 70 μM, respectively. In SPR competition experiments, N-desulfation and 2-O-desulfation had no effect on heparin binding to K18, whereas 6-O-desulfation severely reduced binding, suggesting a critical role for 6-O-sulfation in the tau-heparin interaction. The tau-heparin interaction became stronger with longer-chain heparin oligosaccharides. As expected for an electrostatics-driven interaction, a moderate amount of salt (0.3 M NaCl) abolished binding. NMR showed the largest chemical-shift perturbation (CSP) in R2 in tau K18, which was absent in K19, revealing differential binding sites in K18 and K19 to heparin. Dermatan sulfate binding produced minimal CSP, whereas dermatan disulfate, with the additional 6-O-sulfo group, induced much larger CSP. 2-O-desulfated heparin induced much larger CSP in K18 than 6-O-desulfated heparin. Our data demonstrate a crucial role for the 6-O-sulfo group in the tau-heparin interaction, which to our knowledge has not been reported before.
Copyright © 2017 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28297651      PMCID: PMC5355497          DOI: 10.1016/j.bpj.2017.01.024

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  45 in total

1.  Sulfation patterns of glycosaminoglycans encode molecular recognition and activity.

Authors:  Cristal I Gama; Sarah E Tully; Naoki Sotogaku; Peter M Clark; Manish Rawat; Nagarajan Vaidehi; William A Goddard; Akinori Nishi; Linda C Hsieh-Wilson
Journal:  Nat Chem Biol       Date:  2006-07-30       Impact factor: 15.040

2.  Residual structure in the repeat domain of tau: echoes of microtubule binding and paired helical filament formation.

Authors:  David Eliezer; Patrick Barré; Muris Kobaslija; Dylan Chan; Xiaohua Li; Lauren Heend
Journal:  Biochemistry       Date:  2005-01-25       Impact factor: 3.162

3.  Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure.

Authors:  O Schweers; E Schönbrunn-Hanebeck; A Marx; E Mandelkow
Journal:  J Biol Chem       Date:  1994-09-30       Impact factor: 5.157

4.  The "jaws" of the tau-microtubule interaction.

Authors:  Marco D Mukrasch; Martin von Bergen; Jacek Biernat; Daniela Fischer; Christian Griesinger; Eckhard Mandelkow; Markus Zweckstetter
Journal:  J Biol Chem       Date:  2007-02-15       Impact factor: 5.157

5.  Kinetic and Structural Studies of Interactions between Glycosaminoglycans and Langerin.

Authors:  Jing Zhao; Xinyue Liu; Chelsea Kao; Emily Zhang; Quanhong Li; Fuming Zhang; Robert J Linhardt
Journal:  Biochemistry       Date:  2016-08-03       Impact factor: 3.162

6.  Role of glycosaminoglycans in cellular communication.

Authors:  Robert J Linhardt; Toshihiko Toida
Journal:  Acc Chem Res       Date:  2004-07       Impact factor: 22.384

7.  Importance of Tyr310 residue in the third repeat of microtubule binding domain for filament formation of tau protein.

Authors:  Chisato Nishiura; Kengo Takeuchi; Katsuhiko Minoura; Miho Sumida; Taizo Taniguchi; Koji Tomoo; Toshimasa Ishida
Journal:  J Biochem       Date:  2009-11-06       Impact factor: 3.387

8.  Domain conformation of tau protein studied by solution small-angle X-ray scattering.

Authors:  Efstratios Mylonas; Antje Hascher; Pau Bernadó; Martin Blackledge; Eckhard Mandelkow; Dmitri I Svergun
Journal:  Biochemistry       Date:  2008-09-05       Impact factor: 3.162

Review 9.  Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis.

Authors:  Renato V Iozzo; Jason J Zoeller; Alexander Nyström
Journal:  Mol Cells       Date:  2009-05-15       Impact factor: 5.034

Review 10.  NMR Meets Tau: Insights into Its Function and Pathology.

Authors:  Guy Lippens; Isabelle Landrieu; Caroline Smet; Isabelle Huvent; Neha S Gandhi; Benoît Gigant; Clément Despres; Haoling Qi; Juan Lopez
Journal:  Biomolecules       Date:  2016-06-07
View more
  23 in total

1.  3-O-Sulfation of Heparan Sulfate Enhances Tau Interaction and Cellular Uptake.

Authors:  Jing Zhao; Yanan Zhu; Xuehong Song; Yuanyuan Xiao; Guowei Su; Xinyue Liu; Zhangjie Wang; Yongmei Xu; Jian Liu; David Eliezer; Trudy F Ramlall; Guy Lippens; James Gibson; Fuming Zhang; Robert J Linhardt; Lianchun Wang; Chunyu Wang
Journal:  Angew Chem Int Ed Engl       Date:  2019-12-10       Impact factor: 15.336

2.  HspB1 and Hsc70 chaperones engage distinct tau species and have different inhibitory effects on amyloid formation.

Authors:  Hannah E R Baughman; Amanda F Clouser; Rachel E Klevit; Abhinav Nath
Journal:  J Biol Chem       Date:  2018-01-03       Impact factor: 5.157

3.  Binding and neurotoxicity mitigation of toxic tau oligomers by synthetic heparin like oligosaccharides.

Authors:  Peng Wang; Filippa Lo Cascio; Jia Gao; Rakez Kayed; Xuefei Huang
Journal:  Chem Commun (Camb)       Date:  2018-09-06       Impact factor: 6.222

Review 4.  Glycosaminoglycans in Neurodegenerative Diseases.

Authors:  Weihua Jin; Fuming Zhang; Robert J Linhardt
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

5.  Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus α-synuclein and β-amyloid aggregates.

Authors:  Barbara E Stopschinski; Brandon B Holmes; Gregory M Miller; Victor A Manon; Jaime Vaquer-Alicea; William L Prueitt; Linda C Hsieh-Wilson; Marc I Diamond
Journal:  J Biol Chem       Date:  2018-05-11       Impact factor: 5.157

6.  The distinct structural preferences of tau protein repeat domains.

Authors:  Xuhua Li; Xuewei Dong; Guanghong Wei; Martin Margittai; Ruth Nussinov; Buyong Ma
Journal:  Chem Commun (Camb)       Date:  2018-05-31       Impact factor: 6.222

7.  A synthetic heparinoid blocks Tau aggregate cell uptake and amplification.

Authors:  Barbara E Stopschinski; Talitha L Thomas; Sourena Nadji; Eric Darvish; Linfeng Fan; Brandon B Holmes; Anuja R Modi; Jordan G Finnell; Omar M Kashmer; Sandi Estill-Terpack; Hilda Mirbaha; Hung S Luu; Marc I Diamond
Journal:  J Biol Chem       Date:  2020-01-23       Impact factor: 5.157

Review 8.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

Review 9.  The Sulfation Code of Tauopathies: Heparan Sulfate Proteoglycans in the Prion Like Spread of Tau Pathology.

Authors:  Dylan Mah; Jing Zhao; Xinyue Liu; Fuming Zhang; Jian Liu; Lianchun Wang; Robert Linhardt; Chunyu Wang
Journal:  Front Mol Biosci       Date:  2021-05-20

Review 10.  Tau strains shape disease.

Authors:  Jaime Vaquer-Alicea; Marc I Diamond; Lukasz A Joachimiak
Journal:  Acta Neuropathol       Date:  2021-04-08       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.